Home  /  Resource Library  /  Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

Results of a phase II study investigating maintenance therapy with bortezomib following chemoimmunotherapy and autologous stem cell transplant for first line treatment of mantle cell lymphoma.